Management Discussion and Analysis dated August 24, 2010, to accompany the financial statements for the year ended May 31, 2010

Size: px
Start display at page:

Download "Management Discussion and Analysis dated August 24, 2010, to accompany the financial statements for the year ended May 31, 2010"

Transcription

1 L I F E B A N K TM Corp. Saving Life s Most Precious Cells Technology Place BCIT Campus Suite Wayburne Drive Burnaby, British Columbia V5G 4X4 Tel: Fax: Management Discussion and Analysis dated August 24, 2010, to accompany the financial statements for the year ended May 31, 2010 Caution Regarding Forward Looking Statements This discussion includes statements about our expectations for the future. We believe that our expectations are reasonable; however, actual outcomes may differ materially from our expectations due to changes in operating performance, unexpected competition, advances in medical science, and other technical, market and economic factors. Our Business We, Lifebank Corp., or the Company, are a cryogenic facility engaged in the business of processing and cryopreserving umbilical cord blood stem cells for families. Our facilities and processes have been accredited by the AABB (formerly known as the American Association of Blood Banks) and by the Foundation for the Accreditation of Cellular Therapy (FACT). We are fully Health Canada compliant and are registered with the US Food and Drug Administration. Our goal is to become the premier umbilical cord blood stem cell bank in Canada. We are already the first Canadian cord blood bank, the first AABB accredited cord blood bank in Canada, the first FACT accredited family cord blood bank in North America and the first Canadian bank to accept samples from across the country and internationally. We have been in continuous operation since Stem Cells There are two types of stem cells: adult stem cells (non-embryonic), and embryonic stem cells from aborted fetuses or human embryos grown in a laboratory. Extraction of embryonic stem cells results in the death of the embryo, which raises serious ethical concerns. The use of embryonic stem cells is either illegal or highly restricted in many countries. Adult stem cells are available from three sources: bone marrow, mobilized peripheral blood and umbilical cord blood. Stem cells are the building blocks of both the blood and immune systems. Collection of adult stem cells from either the bone marrow or peripheral blood is invasive and not without risk to the donor. After the birth of an infant, the umbilical cord is filled with blood that contains adult stem cells. This blood can be non-invasively and painlessly collected with no risk to the mother or the infant, resulting in a unit of adult stem cells that can be cryopreserved and stored for future use. Storing an infant s adult stem cells at birth ensures a perfect tissue match for that infant with no chance of rejection, should the stem cells be required for medical treatment. The adult stem cells may also be suitable for siblings or parents. Not surprisingly, reports have suggested that the best results were achieved in patients who received cord blood stem cells from related donors. At present, umbilical cord blood is routinely discarded at birth. Adult stem cell transplants are used to treat a wide range of life threatening illnesses, including leukemia, metabolic disorders, immune deficiencies, bone marrow failure and some genetic disorders. Transplantation centers world-wide have accepted that cord blood is a clinically viable alternative to bone marrow and mobilized peripheral blood as a source of adult stem cells. Research studies indicate that adult stem cells could be used in the development of new treatments for repairing muscle, neural and liver tissue damaged by various human conditions. Recently, Lifebank clients have received a transfusion of their own cord blood sample for experimental procedures to reverse hyperglycemia in children with type 1 diabetes and treatment of cerebral palsy.

2 Stem Cell Banking We currently process and store umbilical cord blood stem cells for families who pay for our services. We are also in discussion with federal and provincial governments regarding economic models for a Canadian public umbilical cord blood stem cell donor bank. Privately stored stem cells are only available to the family who paid to store them. Publically donated stem cells would be available on a medically as needed basis to all Canadians. It would be the goal of a Canadian public bank to store a cross-section of stem cells that reflects the unique, diverse, multi-ethnic make-up of Canadian society. While US and other foreign public stem cell banks may provide matches for Caucasians, Canada s significant First Nations, Asian, South Asian and other populations, especially those who have racially-mixed parentage, are less likely to be matched. We remain committed to supporting a Canadian public donor bank, with appropriate governmental funding, so that all Canadians can benefit from significant medical advances in stem cell utilization. There is no assurance that the economic model adopted by the governments, if any, will directly benefit Lifebank. Our Services We provide three services related to umbilical cord blood stem cell banking: education and registration, processing (extracting the stem cells from the umbilical cord blood) and cryogenic (ultra-low temperature) storage. Expectant parents contact us to process and store their baby s cord blood stem cells. We provide educational materials and answers to their questions and concerns on cord blood banking, using a no-pressure, informed consent model to assist in their decision to bank their baby s cord blood. After the parents register, we provide them a collection kit and further educational materials which are used by their delivering physician or mid-wife to collect the umbilical cord blood. Once the baby is born and the blood has been collected, we arrange to have the collection kit couriered back to us for processing and storage within 48 hours of birth. We charge separate fees for registration, processing and storage and re-bill courier costs to the client. Our Facilities We have occupied our current facility on the campus of the British Columbia Institute of Technology since December It is centrally located within a half-hour drive of all major hospitals in the Greater Vancouver metropolitan area and the Vancouver International Airport. Our operations and laboratory facilities have been accredited by the AABB and FACT, are fully Health Canada compliant and are registered with the US Food and Drug Administration. This is important as it provides assurance to our clients and their physicians that the stem cells have been processed and stored according to stringent medical criteria and best laboratory practice procedures. Our current laboratory facility is sufficient to process the cord blood stem cells from over 400 new clients every month. We continue to purchase additional storage tanks as the number of samples collected increases. We increased our laboratory and office space this year to accommodate additional tanks and increased administrative staff. Discussion of Operations and Financial Condition You should refer to our financial statements for the year ended May 31, 2010 while you read this discussion. Those financial statements summarize the financial impact of our financings, investments and operations and provide significant, material information that is not meant to be, nor is it, included in this discussion. This discussion is meant to provide information not included in the financial statements and an explanation of some of the financial statement information. Our sample processing volumes increased by 38% during the year ended May 31, 2010 over the previous year. This is the result of additional marketing activities started in The additional marketing activities caused us to experience a loss of $292,301, compared to $105,559 last year. Future storage fees from the additional samples brought in during the year are expected to offset these losses in later years.

3 Selected Annual Information (Unaudited) We have summarized selected financial information from the Company s financial statements, which are prepared in Canadian dollars and in accordance with Canadian generally accepted accounting principles. Years ended May 31, Operating Results % of % of % of $ sales $ sales $ sales Revenue 3,390, ,574, ,232, Direct operating expenses 1,441, ,106, , Marketing expenses 910, , , Other expenses 1,382, ,094, , Net (loss) income before tax (343,943) (117,202) , Future income tax recovery (51,642) -1.5 (11,643) -0.5 (640,123) Net (loss) income (292,301) -8.7 (105,559) , Net (loss) income per share, basic diluted (0.030) (0.030) (0.011) (0.011) Cash dividends declared per common share nil nil nil Operating Results $3,500,000 $3,000,000 $2,500,000 $2,000,000 $1,500,000 $1,000,000 $500,000 Revenue Direct operating expenses Marketing and other expenses Net income (loss), before tax $0 -$500, May 31, Financial Position $ $ $ Current assets 1,728,214 1,262, ,218 Other assets 1,723,109 1,626,477 1,467,636 Total assets 3,451,323 2,888,988 2,242,854 Current portion of unearned revenue 737, , ,000 Long-term portion of unearned revenue 2,323,947 1,661,277 1,209,388 Other current liabilities 457, , ,269 Other long-term liabilities 5,183 34,478 56,350 Shareholders (deficiency) equity (72,922) 165, ,847

4 Summary of Quarterly Results (Unaudited) We have summarized selected financial information from the Company s interim financial statements, which are prepared in Canadian dollars and in accordance with Canadian generally accepted accounting principles. $ 000 s Quarters ended May 31 Feb 28 Nov 30 Aug 31 May 31 Feb 28 Nov 30 Aug Revenue Operating expenses Gross margin Marketing expenses Other expenses Net (loss) income before tax (43) (160) (102) (39) (72) (42) (48) 45 Future income tax expense (recovery) 14 (38) (21) (5) (12) (7) (8) 16 Net (loss) income (57) (122) (81) (34) (60) (35) (40) 29 Net (loss) income per share basic $ diluted $ (0.012) (0.012) (0.008) (0.008) (0.003) (0.003) Percent of Revenue Operating expenses 42.0% 42.7% 42.6% 42.7% 43.0% 42.9% 43.2% 43.1% Gross Margin 58.0% 57.3% 57.4% 57.3% 57.0% 57.1% 56.8% 56.9% Results of Operations We incurred a net loss after tax of $292,301 during the year ended May 31, 2010, compared to $105,559 net during the year ended May 31, We incurred a net loss of $56,542 during the three months ended May 31, 2010, compared to $59,870 for the same period last year. Revenue increases during 2010 were offset by increased direct operating and other expenses. Revenues Our revenues for year ended May 31, 2010 were 32% higher than the previous year. Revenues for the three months ended May 31, 2010 were 5% higher than for the same period last year. The growth in revenues is attributable to the increasing volume of samples processed and to the increasing total number of samples in storage. This growth is due to the increased public awareness of cord blood stem cell banking and our marketing activities.

5 Three months ended May 31 Year ended May 31 Revenue $ $ $ $ Storage Fees 340, ,774 1,271,433 1,042,580 Registration Fees 62,465 69, , ,705 Processing Fees 372, ,438 1,642,175 1,196,523 Other Fees 50,340 38, , ,045 Total Revenue 825, ,828 3,390,816 2,574,853 Direct Operating Expenses Operating expenses are expected to vary in direct relation to the number of samples processed, although fluctuations in the ratios normally occur from period to period. Labour efficiencies that result from higher sample processing volumes are the most significant variable. Labour included in direct costs ranged from 12% to 16% of revenue over the last eight quarters and averaged 13.1% during 2010 compared to 14.4% during Processing supplies and services are also significant variables, and have ranged from an average of 24% of revenues to an average of 21% over the last eight quarters. Other Expenses Marketing costs have increased in the current periods over previous periods from increased advertising and participation in industry events. Amortization of property and equipment increased from the addition of new equipment and leasehold improvements. Interest on capital leases decreased because the principal portion of the leases is being repaid. Office and administration expenses increased from higher credit card processing fees, the set-up of improved data processing and storage systems and higher rent from increased lab and office space. General corporate expenses increased because of additional website costs, accounts receivable written off and higher insurance premiums. Administrative personnel costs are higher in 2010 than in 2009 because of higher salary rates and additional office staff. Liquidity, Financial Position and Capital Resources At May 31, 2010 we had cash of $1,364,063, working capital of $533,099 and a shareholders deficiency of $72,922. The working capital is net of a $737,237 current liability from storage fees billed in advance. We will recognize these fees as revenue over the next year. This is an improvement over May 31, 2009 of an additional $298,142 in working capital, including a reduction of $128,194 from an increase in unearned revenue. Our operating cash flows were a surplus of $628,467 during the year ended May 31, $790,864 of the cash flows were from an increase in storage fees paid in advance. Many of our customers are choosing to prepay for 15 to 18 years of storage when the sample is processed. We continue to expect improvements in our operating cash flow as a result of increased revenues and improved operating margins. New laboratory equipment of up to $150,000 will be required over the next year. We plan to pay for this equipment through operating cash flows. Portions of our cash are on deposit in accounts and guaranteed investment certificates that bear interest at current market rates. At the levels on deposit at May 31, 2010, a 1% change in the rate of interest would result in a $10,000 increase or decrease in our annual operating cash flow and net income or loss before income tax. We manage liquidity risk by ensuring that sufficient cash is available to pay financial liabilities within their stated credit terms.

6 New Accounting Policies We did not adopt any new accounting standards during the year ended May 31, 2010 that had a significant effect on our financial statements. We will adopt International Financial Reporting Standards ( IFRS ) effective June 1, There are several differences between IFRS and Canadian GAAP. The differences that could have the most significant impact on our financial statements are the presentation layout, the values assigned to property and equipment, and expanded note disclosure. IFRS require the financial statements comprise a Statement of Financial Position (Balance Sheet), a Statement of Comprehensive Income, a Statement of Changes in Equity, a Statement of Cash Flows and Notes. The Statement of Financial Position is presented in order of relevant importance to the company, not necessarily in order of liquidity as in Canadian GAAP. The Statement of Comprehensive Income is presented with expenses classified either by function (e.g., direct operating expenses, marketing, general and administrative) or by nature (e.g., supplies, labour, depreciation) but not both (which is how our Canadian GAAP Statement of Income and Comprehensive Income is presented). Note disclosure is made of the nature of expenses if the expenses are classified by function. The Statement of Changes in Equity, which is not required under Canadian GAAP, provides a reconciliation between the opening and ending balances of each component of equity. The Statement of Cash Flows under IFRS is similar to Canadian GAAP. Over the next year, we will evaluate the presentation format most suitable to Lifebank. Property and equipment is more rigorously analysed and evaluated under IFRS than under Canadian GAAP. Depreciation rates, expected useful lives and residual values are estimated and adjusted, if necessary, at each reporting period. Depreciation under IFRS commences when the asset is available for use rather than when it is actually placed into use under Canadian GAAP. Impairment losses are recognized under IFRS if the present value of future cash flows (discounted) expected from an asset or group of assets exceeds its carrying amount and losses may be reversed later if the value recovers. Canadian GAAP uses undiscounted cash flows to determine impairment and recognized losses may not be reversed later. The initial adoption rules for IFRS permit us to use the current fair value of our plant and equipment at June 1, 2010 as cost, rather than requiring the onerous task of revaluing 14 years worth of transactions. We will evaluate the most appropriate method of valuing our property and equipment at June 1, 2010 over the next year. The amount shown for property and equipment under IFRS might be materially different from the amount shown under Canadian GAAP. Any difference will be reflected in retained earnings at June 1, Share Capital The company has only one class of share capital, common shares without par value. The number of shares authorized is unlimited. The Company also has a stock option plan that permits the directors of the Company to grant incentive options to the employees, directors, officers and consultants of the Company. The maximum number of shares issuable under the stock option plan is 1,943,000, of which 430,000 have been issued. The following are outstanding at August 24, 2010: Common shares 10,148,361 Shares issuable on the exercise of outstanding stock options 1,235,000 Shares available for future stock option grants 278,000 Related Party Transactions Professional fees during the year ended May 31, 2010 include $27,973 paid to DuMoulin Black LLP, a law firm in which J. Douglas Seppala, one of our directors, is a partner. The payments represent fees for legal services provided to the Company at rates normally charged by unrelated parties. Other Information Additional information relating to the Company is available on the SEDAR website at

Annual General Meeting of Shareholders 19 May 2010

Annual General Meeting of Shareholders 19 May 2010 Annual General Meeting of Shareholders 19 May 2010 2009 results 2010 Q1 highlights Arnoud van Tulder CEO 19 May 2010 www.cryo-savegroup.com Highlights 2009 Strong financial results and cash position year

More information

Digger Resources Inc.

Digger Resources Inc. Financial Statements of Digger Resources Inc. Six Months ended January 31, NOTICE TO READER The accompanying unaudited interim financial statements of Digger Resources Inc. for the six months ended January

More information

AssureImmune. Cord Blood: For Something That Precious, Bank with the Best. Important Facts for When You re Expecting. AssureImmune.

AssureImmune. Cord Blood: For Something That Precious, Bank with the Best. Important Facts for When You re Expecting. AssureImmune. AssureImmune AssureImmune Cord Blood: For Something That Precious, Bank with the Best Important Facts for When You re Expecting Banking your baby s umbilical cord blood could be a potentially lifesaving

More information

NEWS RELEASE. Avcorp announces 2014 Third Quarter Financial Results. November 13, 2014

NEWS RELEASE. Avcorp announces 2014 Third Quarter Financial Results. November 13, 2014 Avcorp announces 2014 Third Quarter Financial Results Avcorp Industries Inc. 10025 River Way Delta, British Columbia Canada V4G 1M7 (604) 582 1137 (604) 582 2620 Fax info@avcorp.com Common Stock Listed

More information

MASUPARIA GOLD CORPORATION

MASUPARIA GOLD CORPORATION CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS THREE MONTHS ENDED DECEMBER 31, 2011 and 2010 (expressed in Canadian Dollars) NOTICE TO READERS Under National Instrument 51-102, Part 4.3 (3)(a), if

More information

CONSOLIDATED FINANCIAL STATEMENTS

CONSOLIDATED FINANCIAL STATEMENTS CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2010 BANKERS PETROLEUM LTD. CONSOLIDATED BALANCE SHEETS (Unaudited, expressed in thousands of US dollars) ASSETS June 30 2010 December 31 2009 Current assets

More information

A Gift for life. HTA Licence No. 22653

A Gift for life. HTA Licence No. 22653 A Gift for life HTA Licence No. 22653 2 3 the best possible gift for your new born child. 4 6 8 9 10 12 14 16 19 what is cord blood current treatments services contents properties for treatment process

More information

Interim Financial Statements. Opsens Inc. (after merger) Three-month period ended November 30, 2006

Interim Financial Statements. Opsens Inc. (after merger) Three-month period ended November 30, 2006 Interim Financial Statements Opsens Inc. (after merger) Three-month period ended Interim Financial Statements Three-month period ended Notice These interim financial statements have not been reviewed by

More information

(An Exploration Stage Company) Condensed Interim Financial Statements (Unaudited Prepared by Management) (Expressed in Canadian Dollars)

(An Exploration Stage Company) Condensed Interim Financial Statements (Unaudited Prepared by Management) (Expressed in Canadian Dollars) Condensed Interim Financial Statements () Corporate Head Office 2300-1177 West Hastings Street Vancouver, BC Canada V6E 2K3 Tel: 604-638-3664 NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL STATEMENTS

More information

FINANCIAL STATEMENTS. Alberta Beverage Container Recycling Corporation. Contents

FINANCIAL STATEMENTS. Alberta Beverage Container Recycling Corporation. Contents 1 FINANCIAL STATEMENTS Alberta Beverage Container Recycling Corporation Contents 2 Independent Auditor s Report 3 Statement of Operations and Changes in Net Assets 4 Statement of Financial Position 5 Statement

More information

Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents

Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents Eileen Quinlan Collection Supervisor, Brampton (GTA) 2015-11-10 History One Match Stem Cell and Marrow

More information

Newborn Blood Banking, Inc. P.O. Box 270067 Tampa, Florida 33688 Phone (813) 948-2673

Newborn Blood Banking, Inc. P.O. Box 270067 Tampa, Florida 33688 Phone (813) 948-2673 Please complete the following forms and send them back to us along with the registration fee to register. Once we receive your registration forms and payment, we will send you the collection kit. Mother

More information

NSS Resources Inc. MANAGEMENT DISCUSSION AND ANALYSIS For the year ended June 30, 2015

NSS Resources Inc. MANAGEMENT DISCUSSION AND ANALYSIS For the year ended June 30, 2015 This Management Discussion and Analysis ( MD&A ) of NSS Resources Inc., ( NSS or the Company or the Issuer ) provides an analysis of the Company s performance and financial condition for the 12 months

More information

Zutphen, 15 May 2013 Arnoud van Tulder Chief Executive Officer

Zutphen, 15 May 2013 Arnoud van Tulder Chief Executive Officer Zutphen, 15 May 2013 Arnoud van Tulder Chief Executive Officer 1 Non-recurring events 2012 Non-recurring costs in 2012 of 16.2 million: - Non-cash impairment of goodwill and other assets: 15.1 million

More information

Sunora Foods Inc. Condensed Interim Consolidated Financial Statements For the three months ended March 31, 2016 (unaudited)

Sunora Foods Inc. Condensed Interim Consolidated Financial Statements For the three months ended March 31, 2016 (unaudited) Condensed Interim Consolidated Financial Statements For the three months ended March 31, 2016 (unaudited) 1 Consolidated Balance Sheet (audited) March 31, December 31, Assets 2016 2015 Current assets Cash

More information

AUDIOTECH HEALTHCARE CORPORATION

AUDIOTECH HEALTHCARE CORPORATION Consolidated Financial Statements of AUDIOTECH HEALTHCARE CORPORATION Year ended September 30, 2008 1 CHARTERED ACCOUNTANTS MacKay LLP 1100 1177 West Hastings Street Vancouver, BC V6E 4T5 Tel: (604) 687-4511

More information

DATA GROUP LTD. ANNOUNCES SECOND QUARTER FINANCIAL RESULTS FOR 2015

DATA GROUP LTD. ANNOUNCES SECOND QUARTER FINANCIAL RESULTS FOR 2015 For Immediate Release DATA GROUP LTD. ANNOUNCES SECOND QUARTER FINANCIAL RESULTS FOR 2015 SECOND QUARTER HIGHLIGHTS Second quarter 2015 ( Q2 ) Revenues of $73.4 million, a decrease of 4.3% year over year

More information

Western Energy Services Corp. Condensed Consolidated Financial Statements September 30, 2015 and 2014 (Unaudited)

Western Energy Services Corp. Condensed Consolidated Financial Statements September 30, 2015 and 2014 (Unaudited) Condensed Consolidated Financial Statements September 30, 2015 and 2014 (Unaudited) Condensed Consolidated Balance Sheets (Unaudited) (thousands of Canadian dollars) Note September 30, 2015 December 31,

More information

A STRONG DECISION FOR A HEALTHY FUTURE

A STRONG DECISION FOR A HEALTHY FUTURE A STRONG DECISION FOR A HEALTHY FUTURE As parents, we always want to be sure we do everything for our children to help them build a strong and healthy future. At ovo biosurance we truly believe that cord

More information

Condensed Interim Financial Statements of MANITOU GOLD INC. Three months ended March 31, 2011 (Unaudited prepared by management)

Condensed Interim Financial Statements of MANITOU GOLD INC. Three months ended March 31, 2011 (Unaudited prepared by management) Condensed Interim Financial Statements of MANITOU GOLD INC. (Unaudited prepared by management) NOTICE TO READER The condensed interim balance sheets of Manitou Gold Inc. as at March 31, 2011 and December

More information

ACADIAN TIMBER CORP. REPORTS FOURTH QUARTER AND YEAR-END RESULTS

ACADIAN TIMBER CORP. REPORTS FOURTH QUARTER AND YEAR-END RESULTS News Release Investors, analysts and other interested parties can access Acadian Timber Corp. s 2015 Fourth Quarter Results conference call via webcast on Thursday, February 11, 2016 at 1:00 p.m. ET at

More information

JUST 5 EASY STEPS FOR CORD BLOOD DONATION...

JUST 5 EASY STEPS FOR CORD BLOOD DONATION... JUST 5 EASY STEPS FOR CORD BLOOD DONATION... STEP 1 Read this Information Kit. STEP 2 Print and fill in the forms. STEP 3 Give completed forms to your healthcare provider or to your hospital RN on day

More information

Transition to International Financial Reporting Standards

Transition to International Financial Reporting Standards Transition to International Financial Reporting Standards Topps Tiles Plc In accordance with IFRS 1, First-time adoption of International Financial Reporting Standards ( IFRS ), Topps Tiles Plc, ( Topps

More information

Interim Financial Statements INTERNATIONAL WATER-GUARD INDUSTRIES INC.

Interim Financial Statements INTERNATIONAL WATER-GUARD INDUSTRIES INC. Interim Financial Statements INTERNATIONAL WATER-GUARD INDUSTRIES INC. Three months ended December 31, 2007 and 2006 Interim Financial Statements of INTERNATIONAL WATER-GUARD INDUSTRIES INC. Notice of

More information

Vita 34 Parents Guide to umbilical Cord Blood Banking. secure first-class innovative

Vita 34 Parents Guide to umbilical Cord Blood Banking. secure first-class innovative Vita 34 Parents Guide to umbilical Cord Blood Banking secure first-class innovative Contents INTRODUCTION 3 THERAPEUTIC USES OF STEM CELLS 4 STEM CELLS IN CANCER TREATMENT STEM CELLS IN THE TREATMENT OF

More information

Pacific Ridge Exploration Ltd. (An Exploration Stage Company)

Pacific Ridge Exploration Ltd. (An Exploration Stage Company) Condensed Interim Financial Statements June 30, 2015 (Unaudited Expressed in Canadian Dollars) Notice to Reader The accompanying unaudited condensed interim financial statements of Pacific Ridge Exploration

More information

QUARTERLY AND YEAR END REPORT BC FORM 51-901F (previously Form 61)

QUARTERLY AND YEAR END REPORT BC FORM 51-901F (previously Form 61) British Columbia Securities Commission QUARTERLY AND YEAR END REPORT BC FORM 51-901F (previously Form 61) INCORPORATED AS PART OF: X Schedule A Schedules B and C (Place X in appropriate category.) ISSUER

More information

FLEET MANAGEMENT SOLUTIONS INC.

FLEET MANAGEMENT SOLUTIONS INC. FLEET MANAGEMENT SOLUTIONS INC. (Formerly: Silverton Mining Corp.) CONSOLIDATED FINANCIAL STATEMENTS (unaudited prepared by management) March 31, 2013 (Expressed in US Dollars) 1 FLEET MANAGEMENT SOLUTIONS

More information

eqube Gaming Limited Management Discussion and Analysis For the Three and Nine Month Periods Ended November 30, 2015

eqube Gaming Limited Management Discussion and Analysis For the Three and Nine Month Periods Ended November 30, 2015 FORM 51-102F1 1. Introduction The following management s discussion and analysis ( MD&A ) for eqube Gaming Limited (the Company ) should be read in conjunction with the Company s unaudited condensed interim

More information

Chesapeake Gold Corp.

Chesapeake Gold Corp. Condensed Consolidated Interim Financial Statements June 30, 2015 Second Quarter (unaudited - expressed in thousands of Canadian dollars, except where indicated) Condensed Consolidated Interim Statements

More information

Symbility Solutions Inc. Interim Condensed Consolidated Financial Statements (Unaudited) Quarter ended March 31, 2016

Symbility Solutions Inc. Interim Condensed Consolidated Financial Statements (Unaudited) Quarter ended March 31, 2016 Interim Condensed Consolidated Financial Statements (Unaudited) Quarter ended Interim Consolidated Statements of Financial Position (Unaudited - In thousands of Canadian dollars) As at Note March 31, 2016

More information

H. R. 2107 IN THE HOUSE OF REPRESENTATIVES

H. R. 2107 IN THE HOUSE OF REPRESENTATIVES I 1TH CONGRESS 1ST SESSION H. R. 2107 To direct the Secretary of Health and Human Services to conduct a public education campaign on umbilical cord blood stem cells, and for other purposes. IN THE HOUSE

More information

Dumfries Mutual Insurance Company Financial Statements For the year ended December 31, 2010

Dumfries Mutual Insurance Company Financial Statements For the year ended December 31, 2010 Dumfries Mutual Insurance Company Financial Statements For the year ended December 31, 2010 Contents Independent Auditors' Report 2 Financial Statements Balance Sheet 3 Statement of Operations and Unappropriated

More information

ELECTRA GOLD LTD. MANAGEMENT DISCUSSION AND ANALYSIS QUARTER ENDED JUNE 30, 2014

ELECTRA GOLD LTD. MANAGEMENT DISCUSSION AND ANALYSIS QUARTER ENDED JUNE 30, 2014 The following Management s Discussion and Analysis, with an approval date of August 26, 2014, should be read together with the unaudited financial statements for the six months ended June 30, 2014 and

More information

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS. (Unaudited)

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS. (Unaudited) CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) For the three months ended 2015 and 2014 This page intentionally left blank. CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

More information

Holloway Lodging Corporation. Interim Consolidated Condensed Financial Statements (Unaudited) June 30, 2015 (in thousands of Canadian dollars)

Holloway Lodging Corporation. Interim Consolidated Condensed Financial Statements (Unaudited) June 30, 2015 (in thousands of Canadian dollars) Interim Consolidated Condensed Financial Statements August 12, Management s Report The accompanying unaudited interim consolidated condensed financial statements of Holloway Lodging Corporation (the Company

More information

Your Cord Blood Donation Options

Your Cord Blood Donation Options Your Cord Blood Donation Options Our Mission To develop and maintain a statewide resource for potentially life-saving cord blood to treat children and adults. What is cord blood? Cord blood is the blood

More information

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries

More information

Unaudited Interim Consolidated Financial Statements March 31, 2011. West African Iron Ore Corp. (formerly Westward Explorations Ltd.

Unaudited Interim Consolidated Financial Statements March 31, 2011. West African Iron Ore Corp. (formerly Westward Explorations Ltd. Unaudited Interim Consolidated Financial Statements March 31, 2011 West African Iron Ore Corp. NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL STATEMENTS These accompanying unaudited interim consolidated

More information

Condensed Interim Financial Statements Fiscal 2012 - First Quarter (Unaudited) For the three month periods ended July 31, 2011 and 2010

Condensed Interim Financial Statements Fiscal 2012 - First Quarter (Unaudited) For the three month periods ended July 31, 2011 and 2010 Condensed Interim Financial Statements Fiscal 2012 - First Quarter (Unaudited) For the three month periods ended July 31, 2011 and 2010 CRITICAL OUTCOME TECHNOLOGIES INC. Page 2 Condensed Interim Financial

More information

Uniserve Communications Corporation

Uniserve Communications Corporation Consolidated financial statements of Uniserve Communications Corporation Nine months ended (Unaudited) NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL STATEMENTS The accompanying unaudited interim Consolidated

More information

CONSOLIDATED FINANCIAL STATEMENTS

CONSOLIDATED FINANCIAL STATEMENTS CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (Expressed in Canadian Dollar) and 2007 Index Balance Sheets Statements of Operations, Comprehensive Loss and Deficit Statements of Cash Flows Notes to Financial

More information

Three months ended. Amounts in thousands, except per share Change Change

Three months ended. Amounts in thousands, except per share Change Change 11-11-11-11-11 Financial Highlights Amounts in thousands, except per share Change Change Performance Six months ended June 30 June 30 Net income........... $ 336,031 286,688 17 % $ 634,559 528,301 20 %

More information

ASSOCIATION OF FUNDRAISING PROFESSIONALS GREATER TORONTO CHAPTER

ASSOCIATION OF FUNDRAISING PROFESSIONALS GREATER TORONTO CHAPTER Financial Statements of ASSOCIATION OF FUNDRAISING PROFESSIONALS INDEPENDENT AUDITORS' REPORT To the Members of ASSOCIATION OF FUNDRAISING PROFESSIONALS We have audited the accompanying financial statements

More information

BIOMARK DIAGNOSTICS INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS. June 30, 2015. (Stated in Canadian Dollars)

BIOMARK DIAGNOSTICS INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS. June 30, 2015. (Stated in Canadian Dollars) CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (Unaudited Prepared by Management) NOTICE OF NO AUDITOR REVIEW OF CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS Under National Instrument 51-102,

More information

INTERACTIVE BROKERS CANADA INC. (a wholly-owned subsidiary of Interactive Brokers Group LLC)

INTERACTIVE BROKERS CANADA INC. (a wholly-owned subsidiary of Interactive Brokers Group LLC) Financial statements of INTERACTIVE BROKERS CANADA INC. (a wholly-owned subsidiary of Interactive Brokers Group LLC) December 31, 2002 Table of contents Auditors report...1 Statement of loss and deficit...2

More information

(Formerly CVTech Group Inc.)

(Formerly CVTech Group Inc.) (Formerly CVTech Group Inc.) Condensed Interim Consolidated Financial Statements For the three months ended, 2014 Consolidated Statement of Financial Position (in thousands of Canadian dollars) December

More information

NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL STATEMENTS

NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL STATEMENTS Condensed Interim Consolidated Financial Statements of THE BRICK LTD. For the three months ended March 31, 2013 NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL STATEMENTS Under National Instrument 51-102,

More information

QUARTERLY REPORT Q3 2010. Third Quarter Report for the period ended September 30, 2010

QUARTERLY REPORT Q3 2010. Third Quarter Report for the period ended September 30, 2010 QUARTERLY REPORT Q3 2010 Third Quarter Report for the period September 30, 2010 CIRCA ENTERPRISES INC. 2 MANAGEMENT S DISCUSSION AND ANALYSIS AS AT AND FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER

More information

Consolidated Financial Statements (In Canadian dollars) ACUITYADS INC. Years ended December 31, 2013, 2012 and 2011

Consolidated Financial Statements (In Canadian dollars) ACUITYADS INC. Years ended December 31, 2013, 2012 and 2011 Consolidated Financial Statements ACUITYADS INC. KPMG LLP Telephone (416) 228-7000 Yonge Corporate Centre Fax (416) 228-7123 4100 Yonge Street Suite 200 Internet www.kpmg.ca Toronto ON M2P 2H3 Canada To

More information

Pivot Technology Solutions, Inc.

Pivot Technology Solutions, Inc. Interim Condensed Consolidated Financial Statements Pivot Technology Solutions, Inc. For the Three Months Ended (Unaudited) (Expressed in Thousands of U.S. Dollars) INTERIM CONDENSED CONSOLIDATED STATEMENTS

More information

It s not something you want to think about, but it s something you want to prepare for.

It s not something you want to think about, but it s something you want to prepare for. It s not something you want to think about, but it s something you want to prepare for. StemCyte cord blood banking offers your family a new lifesaving treatment alternative Why Bank Take the once-in-alifetime

More information

Consolidated Financial Statements. Forestry Innovation Investment Ltd. March 31, 2014

Consolidated Financial Statements. Forestry Innovation Investment Ltd. March 31, 2014 Consolidated Financial Statements Forestry Innovation Investment Ltd. Contents Page Independent Auditor's Report 1-2 Consolidated Statement of Financial Position 3 Consolidated Statement of Operations

More information

cord blood saves lives...

cord blood saves lives... cord blood saves lives... ...by providing a rich source of blood stem cells that can be used to treat over 80 different diseases including leukemia, lymphoma, thalassemia, Tay-Sachs and sickle cell anemia.

More information

Consolidated Financial Statements of

Consolidated Financial Statements of Consolidated Financial Statements of KPMG LLP Telephone (613) 212-KPMG Chartered Accountants Fax (613) 212-2896 Suite 2000 Internet www.kpmg.ca 160 Elgin Street Ottawa, ON K2P 2P8 Canada INDEPENDENT AUDITORS

More information

ALLIANCE PIPELINE LIMITED PARTNERSHIP Statements of Income. September 30 2013 2012 (1) 2013 2012 (1) (unaudited, thousands of Canadian dollars)

ALLIANCE PIPELINE LIMITED PARTNERSHIP Statements of Income. September 30 2013 2012 (1) 2013 2012 (1) (unaudited, thousands of Canadian dollars) ALLIANCE PIPELINE LIMITED PARTNERSHIP Statements of Income Three Months Ended Nine Months Ended 2012 (1) 2012 (1) (unaudited, thousands of Canadian dollars) Revenues Transportation revenue (Note 3) 102,537

More information

Condensed Interim Consolidated Financial Statements Three months ended July 31, 2012 (Unaudited)

Condensed Interim Consolidated Financial Statements Three months ended July 31, 2012 (Unaudited) Condensed Interim Consolidated Financial Statements Three months ended July 31, 2012 (Unaudited) 500 435-4 th Avenue S.W. Calgary, AB T2P 3A8 Tel: 403-984-9798 NOTICE TO READER These condensed interim

More information

CEMATRIX CORPORATION Consolidated Financial Statements (in Canadian dollars) September 30, 2015

CEMATRIX CORPORATION Consolidated Financial Statements (in Canadian dollars) September 30, 2015 Consolidated Financial Statements September 30, 2015 Management s Responsibility for Financial Reporting and Notice of No Auditor Review of the Interim Consolidated Financial Statements for the Three and

More information

Stem Cell Quick Guide: Stem Cell Basics

Stem Cell Quick Guide: Stem Cell Basics Stem Cell Quick Guide: Stem Cell Basics What is a Stem Cell? Stem cells are the starting point from which the rest of the body grows. The adult human body is made up of hundreds of millions of different

More information

College of Physicians and Surgeons of British Columbia

College of Physicians and Surgeons of British Columbia Financial Statements OF College of Physicians and Surgeons of British Columbia FEBRUARY 29, 2012 Table of contents Independent Auditor s Report... 1 Statement of operations... 2 Statement of changes in

More information

TITAN MEDICAL INC. Unaudited Condensed Interim Financial Statements Three and Six Months Ended June 30, 2013 and 2012

TITAN MEDICAL INC. Unaudited Condensed Interim Financial Statements Three and Six Months Ended June 30, 2013 and 2012 Unaudited Condensed Interim Financial Statements Three and and 2012 Unaudited Condensed Interim Balance Sheets As at June 30, 2013 and December 31, 2012 ASSETS CURRENT June 30, 2013 December 31, 2012 Cash

More information

LES EXPLOSIFS NORDEX LTEE/NORDEX EXPLOSIVES LTD.

LES EXPLOSIFS NORDEX LTEE/NORDEX EXPLOSIVES LTD. LES EXPLOSIFS NORDEX LTEE/NORDEX EXPLOSIVES LTD. INTERIM MANAGEMENT DISCUSSION AND ANALYSIS of Financial Condition and Results of Operations for the three months ended September 30, 2005 Dated: November

More information

DATA GROUP LTD. ANNOUNCES FIRST QUARTER RESULTS FOR 2014

DATA GROUP LTD. ANNOUNCES FIRST QUARTER RESULTS FOR 2014 For Immediate Release DATA GROUP LTD. ANNOUNCES FIRST QUARTER RESULTS FOR 2014 HIGHLIGHTS Q1 2014 First quarter 2014 ( Q1 ) Revenues of 77.9 million, Q1 Gross Profit of 18.8 million and Q1 Net Income of

More information

A&W Food Services of Canada Inc. Consolidated Financial Statements December 30, 2012 and January 1, 2012 (in thousands of dollars)

A&W Food Services of Canada Inc. Consolidated Financial Statements December 30, 2012 and January 1, 2012 (in thousands of dollars) A&W Food Services of Canada Inc. Consolidated Financial Statements December 30, and January 1, (in thousands of dollars) February 12, 2013 Independent Auditor s Report To the Shareholders of A&W Food Services

More information

FORM 51 102F4 BUSINESS ACQUISITION REPORT

FORM 51 102F4 BUSINESS ACQUISITION REPORT FORM 51 102F4 BUSINESS ACQUISITION REPORT 1. IDENTITY OF COMPANY 1.1 Name and Address of Company Antibe Therapeutics Inc. (the Company ) 15 Prince Arthur Avenue Toronto, Ontario M5R 1B2 1.2 Executive Officer

More information

TIMIA CAPITAL CORP. (the Company ) (FORMERLY GREENANGEL ENERGY CORP.) MANAGEMENT DISCUSSION AND ANALYSIS in Form 51-102F1 ( MD&A )

TIMIA CAPITAL CORP. (the Company ) (FORMERLY GREENANGEL ENERGY CORP.) MANAGEMENT DISCUSSION AND ANALYSIS in Form 51-102F1 ( MD&A ) TIMIA CAPITAL CORP. (the Company ) (FORMERLY GREENANGEL ENERGY CORP.) MANAGEMENT DISCUSSION AND ANALYSIS in Form 51-102F1 ( MD&A ) The following discussion and analysis is for the three months ended February

More information

Your Cord Blood Donation Options

Your Cord Blood Donation Options Your Cord Blood Donation Options What is cord blood? Cord blood is the blood that remains in the placenta after a baby is born. Cord blood has been found to be a rich source of stem cells and can be used

More information

Condensed Interim Financial Statements Fiscal 2013 First Quarter (Unaudited) For the three months ended July 31, 2012 and 2011

Condensed Interim Financial Statements Fiscal 2013 First Quarter (Unaudited) For the three months ended July 31, 2012 and 2011 Condensed Interim Financial Statements Fiscal 2013 First Quarter (Unaudited) CRITICAL OUTCOME TECHNOLOGIES INC Page 2 Condensed Interim Financial Statements Table of Contents Notice of No Audit or Review

More information

HSBC FINANCE CORPORATION

HSBC FINANCE CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period

More information

TITAN MEDICAL INC. Unaudited Condensed Interim Financial Statements Three and Nine Months Ended September 30, 2014 and 2013 (IN UNITED STATES DOLLARS)

TITAN MEDICAL INC. Unaudited Condensed Interim Financial Statements Three and Nine Months Ended September 30, 2014 and 2013 (IN UNITED STATES DOLLARS) Unaudited Condensed Interim Financial Statements and 2013 (IN UNITED STATES DOLLARS) Unaudited Condensed Interim Balance Sheets As at September 30, 2014 and December 31, 2013 ASSETS CURRENT September 30,

More information

AMENDED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS PERIOD ENDED JULY 31, 2015. (Expressed in Canadian Dollars)

AMENDED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS PERIOD ENDED JULY 31, 2015. (Expressed in Canadian Dollars) AMENDED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS PERIOD ENDED JULY 31, 2015 1 NOTICE OF NO AUDITOR REVIEW OF CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS Under National Instrument 51-102,

More information

Save up to 25% off stem cell banking with Netcells Biosciences

Save up to 25% off stem cell banking with Netcells Biosciences Save up to 25% off stem cell banking with Netcells Biosciences In a unique offering, we have been able to arrange an exclusive offer for medical scheme members with Netcells Biosciences Africa s leading

More information

Condensed Interim Consolidated Financial Statements Six months ended October 31, 2011 (Unaudited)

Condensed Interim Consolidated Financial Statements Six months ended October 31, 2011 (Unaudited) Condensed Interim Consolidated Financial Statements Six months ended October 31, 2011 (Unaudited) 500 435-4 th Avenue S.W. Calgary, AB T2P 3A8 Tel: 403-984-9798 NOTICE TO READER These condensed interim

More information

MOUNTAIN EQUIPMENT CO-OPERATIVE

MOUNTAIN EQUIPMENT CO-OPERATIVE Consolidated Financial Statements of MOUNTAIN EQUIPMENT CO-OPERATIVE KPMG LLP PO Box 10426 777 Dunsmuir Street Vancouver BC V7Y 1K3 Canada Telephone (604) 691-3000 Fax (604) 691-3031 Internet www.kpmg.ca

More information

Illustrative Financial Statements Prepared Using the Financial Reporting Framework for Small- and Medium-Entities

Illustrative Financial Statements Prepared Using the Financial Reporting Framework for Small- and Medium-Entities Illustrative Financial Statements Prepared Using the Financial Reporting Framework for Small- and Medium-Entities Illustrative Financial Statements This component of the toolkit contains sample financial

More information

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER 30, 2013 AND 2012.

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER 30, 2013 AND 2012. CONDENSED (Unaudited) (presented in Canadian dollars unless otherwise noted) CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION December 31 As at 2013 2012 Note $ $ Assets Current assets Cash

More information

ZENN Motor Company Inc.

ZENN Motor Company Inc. Interim Consolidated Financial Statements For the three and six months ended Unaudited Notice to Reader The accompanying unaudited interim consolidated financial statements of ZENN Motor Company Inc. (the

More information

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and

More information

COBRA VENTURE CORPORATION. INTERIM FINANCIAL STATEMENTS (Unaudited Prepared by Management) THREE MONTHS ENDED FEBRUARY 28, 2009

COBRA VENTURE CORPORATION. INTERIM FINANCIAL STATEMENTS (Unaudited Prepared by Management) THREE MONTHS ENDED FEBRUARY 28, 2009 INTERIM FINANCIAL STATEMENTS THREE MONTHS ENDED 1 UNAUDITED INTERIM FINANCIAL STATEMENTS In accordance with National Instrument 51-102 released by the Canadian Securities Administrators, the Company discloses

More information

AMAG to Acquire Cord Blood Registry

AMAG to Acquire Cord Blood Registry to Acquire Cord Blood Registry June 29, Pharmaceuticals, Inc. 1100 Winter Street Waltham, MA 02451 o 617.498.3300 A SPECIALTY PHARMACEUTICAL COMPANY DEDICATED TO BRINGING TO MARKET THERAPIES THAT IMPROVE

More information

Interim Condensed Consolidated Financial Statements NOBLE IRON INC. For the three months ended March 31, 2014 and 2013 (Unaudited)

Interim Condensed Consolidated Financial Statements NOBLE IRON INC. For the three months ended March 31, 2014 and 2013 (Unaudited) Interim Condensed Consolidated Financial Statements NOBLE IRON INC. MANAGEMENT S COMMENTS ON UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL

More information

Condensed Consolidated Interim Financial Statements Three Months Ended May 31, 2013 (Unaudited prepared by Management) (Expressed in Canadian

Condensed Consolidated Interim Financial Statements Three Months Ended May 31, 2013 (Unaudited prepared by Management) (Expressed in Canadian Condensed Consolidated Interim Financial Statements Three Months Ended May 31, 2013 (Unaudited prepared by Management) (Expressed in Canadian Dollars) 1 Condensed Consolidated Unaudited Interim Financial

More information

eqube Gaming Limited Condensed Interim Consolidated Financial Statements For the Three and Nine Months Ended November 30, 2015 (Unaudited)

eqube Gaming Limited Condensed Interim Consolidated Financial Statements For the Three and Nine Months Ended November 30, 2015 (Unaudited) Condensed Interim Consolidated Financial Statements For the Three and Nine Months Ended November 30, 2015 Notice to Reader The following interim consolidated financial statements and notes have not been

More information

Management s Discussion & Analysis Period Ended March 31, 2004 as compared to March 31, 2003

Management s Discussion & Analysis Period Ended March 31, 2004 as compared to March 31, 2003 SUITE 700, 505 THIRD STREET S.W., CALGARY, ALBERTA T2P 3E6 FACSIMILE (403)264-7189 TELEPHONE (403)693-1700 Management s Discussion & Analysis March 31, 2004 as compared to March 31, 2003 This Management

More information

FALCON OIL & GAS LTD.

FALCON OIL & GAS LTD. Interim Condensed Consolidated Financial Statements Three and Six Months Ended June 30, 2012 and 2011 (Presented in U.S. Dollars) Interim Condensed Consolidated Statements of Financial Position (Unaudited)

More information

House Resolution No. 37

House Resolution No. 37 california legislature regular session House Resolution No. Introduced by Assembly Member Hill August, House Resolution No. Relative to umbilical cord blood banking. WHEREAS, Since the first umbilical

More information

(unaudited expressed in Canadian Dollars)

(unaudited expressed in Canadian Dollars) Condensed Consolidated Interim Financial Statements of CARGOJET INC. For the three month periods ended (unaudited expressed in Canadian Dollars) This page intentionally left blank Condensed Consolidated

More information

OneMatch National. Sue Smith, Executive Director, Stem Cells 2011-11- 04

OneMatch National. Sue Smith, Executive Director, Stem Cells 2011-11- 04 OneMatch National Public Cord Blood Bank Blood Matters 2011 Sue Smith, Executive Director, Stem Cells 2011-11- 04 No Disclosures To Declare The presenter does not have any involvement with the industry

More information

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE What are Stem Cells? Stem cells are the basic building blocks of all the cells, tissues and organs in the human body. The role of the stem

More information

LEXAM VG GOLD INC. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS March 31, 2015 (Unaudited)

LEXAM VG GOLD INC. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS March 31, 2015 (Unaudited) CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS March 31, 2015 (Unaudited) INDEX Page Condensed Interim Consolidated Statements of Financial Position 3 Condensed Interim Consolidated Statements of

More information

Forward-Looking Statements

Forward-Looking Statements MANAGEMENT S DISCUSSION AND ANALYSIS For the three months ended March 31, 2010 Dated May 21, 2010 Management's Discussion and Analysis ( MD&A ) is intended to help shareholders, analysts and other readers

More information

your complete stem cell bank

your complete stem cell bank your complete stem cell bank HYDERABAD - 88985 000 888, WARANGAL - 8297 256 777 VISAKHAPATNAM - 7799 990 774 VIJAYAWADA AND GUNTUR - 7799 990 771 NELLORE - 7799 990 772, KADAPA - 8297 256 700 RAJAHMUNDRY

More information

China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010

China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010 China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010 Annual Revenue up 34.4% to RMB 261.5 Million Fiscal 2010 New Subscribers grew 30.5% Conference Call

More information

GEOLOGIX EXPLORATIONS INC. CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2003

GEOLOGIX EXPLORATIONS INC. CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2003 CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2003 AUDITORS REPORT To the Shareholders of Geologix Explorations Inc.: We have audited the consolidated balance sheets of Geologix Explorations Inc. as at

More information

MANAGEMENT S DISCUSSION & ANALYSIS

MANAGEMENT S DISCUSSION & ANALYSIS This management discussion and analysis ( MD&A ) of the financial condition and results of operations of Aphria Inc., (the Company or Aphria ), is for the three and six months ended November 30, 2015.

More information

QUARTERLY AND YEAR END REPORT BC FORM 51-901F (previously Form 61)

QUARTERLY AND YEAR END REPORT BC FORM 51-901F (previously Form 61) British Columbia Securities Commission QUARTERLY AND YEAR END REPORT BC FORM 51-901F (previously Form 61) Freedom of Information and Protection of Privacy Act: The personal information requested on this

More information

Acceleware Corp. Interim Financial Statements (Unaudited) For the Three Months Ended March 31, 2011 and 2010 (in Canadian dollars)

Acceleware Corp. Interim Financial Statements (Unaudited) For the Three Months Ended March 31, 2011 and 2010 (in Canadian dollars) Interim Financial Statements (Unaudited) For the Three Months Ended Interim Financial Statements (Unaudited) For the Three Months Ended Contents Statements of Financial Position 2 Statements of Comprehensive

More information

Large Company Limited. Report and Accounts. 31 December 2009

Large Company Limited. Report and Accounts. 31 December 2009 Registered number 123456 Large Company Limited Report and Accounts 31 December 2009 Report and accounts Contents Page Company information 1 Directors' report 2 Statement of directors' responsibilities

More information

DEFIANCE SILVER CORP. (an exploration stage company) CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED DECEMBER 31, 2015

DEFIANCE SILVER CORP. (an exploration stage company) CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED DECEMBER 31, 2015 (an exploration stage company) CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED DECEMBER 31, (expressed in Canadian dollars) NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL

More information

AcuityAds Inc. Condensed Consolidated Interim Financial Statements. Three months ended March 31, 2014 and 2013 (Unaudited)

AcuityAds Inc. Condensed Consolidated Interim Financial Statements. Three months ended March 31, 2014 and 2013 (Unaudited) AcuityAds Inc. Condensed Consolidated Interim Financial Statements Condensed Consolidated Interim Statements of Financial Position March 31, December 31, 2014 2013 Assets Current assets: Cash $ 446,034

More information